from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1025/-

LFCtreatmentdescriptionclass of inhibitor

0.031

Amikacinug/mL Amikacintranslation

-0.711

Cap5-10ug/mL Capreomycintranslation

-0.743

Rox10-50 ug/mL Roxithromycintranslation

-0.281

SM2-5 ug/mL Streptomycintranslation

-1.109

Tet5-10 ug/mL Tetracyclinetranslation

-0.113

Rif0.2-5ug/mL Rifampicintranscription

-0.039

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.410

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.124

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.157

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

7.086

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.364

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.136

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.951

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.917

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.567

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.274

Nigericin50 uM Nigericinrespiration

0.095

TRC10-150 ug/mL Triclosanrespiration

5.495

TRZ10-25 ug/mL Thioridazinerespiration

1.206

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

1.337

menadione6-10 ug/mL Menadionerespiration

-0.621

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.107

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.638

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.000

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.378

NRP_1Non-replicating persistence stage 1dosRassociated

-0.133

Amp0.2mg/mL AmpicillincellWall

0.881

Cephalexin20-100 ug/mL CephalexincellWall

-0.328

Cerulenin0.32-5 ug/mL CerulenincellWall

0.088

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.207

EMB10-20 ug/mL EthambutolcellWall

0.151

Eta12-40 ug/mL EthionamidecellWall

0.576

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.399

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.053

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.199

BZA0.12 mg/mL BenzamidearomaticAmides

-0.093

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.200

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.721

H2O24 mM hydrogen peroxideDNAdamaging

0.288

Levo10 ug/mL LevofloxacinDNAdamaging

-0.823

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.265

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.349

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.430

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.373

Antimycin12.5-50 ug/mL Antimycin A?

-0.388

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.291

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.430

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.079

PA8240.2-2 ug/mL PA-824?

0.899

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.707

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

1.904

mercaptoethanol2 mM 2-Mercaptoethanol?

0.000

methoxatin10-20 ug/mL Methoxatin?